Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.33
+0.29 (1.38%)
At close: Mar 9, 2026, 4:00 PM EDT
21.40
+0.07 (0.33%)
After-hours: Mar 9, 2026, 5:19 PM EDT
Immunome Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,413 | 2,370 | 663 | 457 | 27 | 157 | |
| Market Cap Growth | 191.90% | 257.53% | 44.98% | 1605.70% | -82.91% | 53.68% | |
| Enterprise Value | 1,694 | 2,101 | 425 | 367 | -0 | 101 | |
| Last Close Price | 21.04 | 21.48 | 10.62 | 10.70 | 2.21 | 12.96 | |
| PS Ratio | 337.72 | 341.44 | 73.32 | 32.62 | - | - | |
| PB Ratio | 3.75 | 3.74 | 3.66 | 3.81 | 1.61 | 3.26 | |
| P/TBV Ratio | 3.70 | 3.74 | 3.66 | 3.81 | 1.61 | 3.26 | |
| EV/Sales Ratio | 244.13 | 302.74 | 47.06 | 26.18 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | - | |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.17 | -1.14 | -1.20 | -1.02 | |
| Net Debt / EBITDA Ratio | 3.07 | 3.07 | 1.40 | 4.83 | 0.55 | 2.01 | |
| Net Debt / FCF Ratio | 3.24 | 3.24 | 1.80 | 16.25 | 0.69 | 2.69 | |
| Asset Turnover | 0.02 | 0.02 | 0.05 | 0.16 | - | - | |
| Quick Ratio | 14.53 | 14.53 | 4.00 | 6.33 | 2.89 | 5.50 | |
| Current Ratio | 14.69 | 14.69 | 4.08 | 6.63 | 3.09 | 5.82 | |
| Return on Equity (ROE) | -52.09% | -52.09% | -194.63% | -156.45% | -113.81% | -55.20% | |
| Return on Assets (ROA) | -28.98% | -28.98% | -49.34% | -20.81% | -56.27% | -30.75% | |
| Return on Capital Employed (ROCE) | -33.50% | -33.50% | -82.50% | -22.70% | -220.80% | -52.30% | |
| Earnings Yield | -9.06% | -8.96% | -44.20% | -23.36% | -137.65% | -15.76% | |
| FCF Yield | -8.56% | -8.46% | -17.80% | -1.84% | -107.96% | -11.67% | |
| Buyback Yield / Dilution | -48.96% | -48.96% | -195.51% | -63.64% | -5.10% | -240.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.